Literature DB >> 26392257

Cholestatic liver (dys)function during sepsis and other critical illnesses.

Marc Jenniskens1, Lies Langouche1, Yoo-Mee Vanwijngaerden1, Dieter Mesotten1, Greet Van den Berghe2.   

Abstract

OBJECTIVE: In ICU patients, abnormal liver tests are common. Markers of cholestasis are associated with adverse outcome. Research has focused on the possibility that mild hyperbilirubinemia, instead of indicating inadvertent cholestasis, may be adaptive and beneficial. These new insights are reviewed and integrated in the state-of-the-art knowledge on hepatobiliary alterations during sepsis and other critical illnesses. DATA SOURCES: Relevant publications were searched in Medline with search terms bile, bile acids, cholestasis, critical illness, intensive care, sepsis, alone or in combination. DATA SYNTHESIS: Studies have shown that bilirubin, but also bile acids, the main active constitutes of bile, are increased in plasma of patients with critical illnesses. In particular the conjugated fractions of bilirubin and bile acids are high, indicating that during critical illness the liver is capable of converting these molecules to less toxic forms. In human liver biopsies of prolonged critically ill patients, expression of bile acid excretion pumps towards the bile canaliculi was lower, while alternative transporters towards the systemic circulation were upregulated. Remarkably, in the presence of increased circulating bile acids, expression of enzymes controlling synthesis of bile acids was not suppressed. This suggested loss of feedback inhibition of bile acids synthesis, possibly explained by the observed cytoplasmic retention of the nuclear FXR/RXR heterodimer. As macronutrient restriction during acute critical illness, an intervention that improved outcome, was found to further increase plasma bilirubin while reducing other markers of cholestasis, a potentially protective role of hyperbilirubinemia was suggested.
CONCLUSION: The increase in circulating levels of conjugated bile acids and bilirubin in response to acute sepsis/critical illnesses may not necessarily point to cholestasis as a pathophysiological entity. Instead it may be the result of an adaptively altered bile acid production and transport back towards the systemic circulation. How these changes could be beneficial for survival should be further investigated.

Entities:  

Keywords:  Bile acids; Bilirubin; Cholestasis; Critical illness; Drug-induced cholestasis; Liver; Parenteral nutrition; Sepsis

Mesh:

Substances:

Year:  2015        PMID: 26392257     DOI: 10.1007/s00134-015-4054-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  84 in total

Review 1.  Sepsis and cholestasis: basic findings in the sinusoid and bile canaliculus.

Authors:  K Hirata; S Ikeda; T Honma; T Mitaka; T Furuhata; T Katsuramaki; F Hata; M Mukaiya
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

2.  Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.

Authors:  Yoo-Mee Vanwijngaerden; Joost Wauters; Lies Langouche; Sarah Vander Perre; Christopher Liddle; Sally Coulter; Sara Vanderborght; Tania Roskams; Alexander Wilmer; Greet Van den Berghe; Dieter Mesotten
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

3.  Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver.

Authors:  C J Soroka; J M Lee; F Azzaroli; J L Boyer
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

4.  Abnormal liver function in relation to hemodynamic profile in heart failure patients.

Authors:  V M van Deursen; K Damman; H L Hillege; A P van Beek; D J van Veldhuisen; A A Voors
Journal:  J Card Fail       Date:  2009-09-26       Impact factor: 5.712

5.  Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS.

Authors:  Markus G Donner; Ulrich Warskulat; Nirmalendu Saha; Dieter Häussinger
Journal:  Biol Chem       Date:  2004 Mar-Apr       Impact factor: 3.915

Review 6.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

Review 7.  Hypoxic liver injury and cholestasis in critically ill patients.

Authors:  Thomas Horvatits; Michael Trauner; Valentin Fuhrmann
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

8.  Hepatic dysfunction increases length of stay and risk of death after injury.

Authors:  Brian G Harbrecht; Mazen S Zenati; Howard R Doyle; John McMichael; Ricard N Townsend; Keith D Clancy; Andrew B Peitzman
Journal:  J Trauma       Date:  2002-09

9.  Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats.

Authors:  Weizheng W Wang; Darcey L H Smith; Stephen D Zucker
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

10.  Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model.

Authors:  Falk A Gonnert; Peter Recknagel; Ingrid Hilger; Ralf A Claus; Michael Bauer; Andreas Kortgen
Journal:  Crit Care       Date:  2013-04-10       Impact factor: 9.097

View more
  27 in total

1.  Focus on nutrition and glucose control in the intensive care unit: recent advances and debates.

Authors:  Jean Reignier; Kenneth B Christopher; Yaseen Arabi
Journal:  Intensive Care Med       Date:  2017-10-10       Impact factor: 17.440

2.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

3.  Liver impairment in critical illness and sepsis: the dawn of new biomarkers?

Authors:  Martin Kluge; Frank Tacke
Journal:  Ann Transl Med       Date:  2019-12

4.  Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2.

Authors:  Chuan Hong; Harrison G Zhang; Sehi L'Yi; Andrew South; Gabriel A Brat; T Cai; Griffin Weber; Paul Avillach; Bryce W Q Tan; Alba Gutiérrez-Sacristán; Clara-Lea Bonzel; Nathan P Palmer; Alberto Malovini; Valentina Tibollo; Yuan Luo; Meghan R Hutch; Molei Liu; Florence Bourgeois; Riccardo Bellazzi; Luca Chiovato; Fernando J Sanz Vidorreta; Trang T Le; Xuan Wang; William Yuan; Antoine Neuraz; Vincent Benoit; Bertrand Moal; Michele Morris; David A Hanauer; Sarah Maidlow; Kavishwar Wagholikar; Shawn Murphy; Hossein Estiri; Adeline Makoudjou; Patric Tippmann; Jeffery Klann; Robert W Follett; Nils Gehlenborg; Gilbert S Omenn; Zongqi Xia; Arianna Dagliati; Shyam Visweswaran; Lav P Patel; Danielle L Mowery; Emily R Schriver; Malarkodi Jebathilagam Samayamuthu; Ramakanth Kavuluru; Sara Lozano-Zahonero; Daniela Zöller; Amelia L M Tan; Byorn W L Tan; Kee Yuan Ngiam; John H Holmes; Petra Schubert; Kelly Cho; Yuk-Lam Ho; Brett K Beaulieu-Jones; Miguel Pedrera-Jiménez; Noelia García-Barrio; Pablo Serrano-Balazote; Isaac Kohane
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

5.  Development and validation of a predictive model for in-hospital mortality in patients with sepsis-associated liver injury.

Authors:  Yousheng Liu; Run Sun; Haiyan Jiang; Guiwen Liang; Zhongwei Huang; Lei Qi; Juying Lu
Journal:  Ann Transl Med       Date:  2022-09

Review 6.  Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors:  Claudia D Fuchs; Michael Trauner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

7.  Host Metabolic Response in Early Lyme Disease.

Authors:  Bryna L Fitzgerald; Claudia R Molins; M Nurul Islam; Barbara Graham; Petronella R Hove; Gary P Wormser; Linden Hu; Laura V Ashton; John T Belisle
Journal:  J Proteome Res       Date:  2020-01-09       Impact factor: 4.466

Review 8.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

9.  Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.

Authors:  Jason Wagner; Victor Garcia-Rodriguez; Abraham Yu; Barbara Dutra; Scott Larson; Brooks Cash; Andrew DuPont; Ahmad Farooq
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

10.  Modelling severe Staphylococcus aureus sepsis in conscious pigs: are implications for animal welfare justified?

Authors:  Helle G Olsen; Mads Kjelgaard-Hansen; Pernille Tveden-Nyborg; Malene M Birck; Karsten P Hammelev; Andreas Vegge; Bent Aalbæk; Páll S Leifsson; Henrik E Jensen; Tine Iburg; Peter M H Heegaard; Ole L Nielsen
Journal:  BMC Res Notes       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.